Home  »  Stock   »  Defying the odds and beating analyst forecasts: Ri...

Defying the odds and beating analyst forecasts: Rigel Pharmaceuticals Inc. (RIGL)

Let’s start up with the current stock price of Rigel Pharmaceuticals Inc. (RIGL), which is $1.83 to be very precise. The Stock rose vividly during the last session to $2.04 after opening rate of $2.04 while the lowest price it went was recorded $1.765 before closing at $2.00.Recently in News on January 18, 2023, National Comprehensive Cancer Network® Adds Newly Approved REZLIDHIA™ (olutasidenib) to Clinical Practice Guidelines in Oncology for Acute Myeloid Leukemia. Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that REZLIDHIA™ (olutasidenib) has been added by the National Comprehensive Cancer Network® (NCCN®) to the latest NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for acute myeloid leukemia (AML). REZLIDHIA (olutasidenib) is now included as a recommended targeted therapy for adult patients with relapsed/refractory (R/R) AML with isocitrate dehydrogenase-1 (IDH1) mutation. You can read further details here

Rigel Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.04 on 01/23/23, with the lowest value was $1.19 for the same time period, recorded on 01/06/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Rigel Pharmaceuticals Inc. (RIGL) full year performance was -20.43%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Rigel Pharmaceuticals Inc. shares are logging -47.94% during the 52-week period from high price, and 185.94% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.64 and $3.52.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4614775 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Rigel Pharmaceuticals Inc. (RIGL) recorded performance in the market was 22.00%, having the revenues showcasing 128.55% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 297.28M, as it employees total of 165 workers.

Market experts do have their say about Rigel Pharmaceuticals Inc. (RIGL)

During the last month, 0 analysts gave the Rigel Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.10, with a change in the price was noted +0.42. In a similar fashion, Rigel Pharmaceuticals Inc. posted a movement of +29.79% for the period of last 100 days, recording 3,830,826 in trading volumes.

Technical breakdown of Rigel Pharmaceuticals Inc. (RIGL)

Raw Stochastic average of Rigel Pharmaceuticals Inc. in the period of last 50 days is set at 84.69%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 77.42%. In the last 20 days, the company’s Stochastic %K was 88.07% and its Stochastic %D was recorded 91.82%.

Bearing in mind the latest performance of Rigel Pharmaceuticals Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 22.00%. Additionally, trading for the stock in the period of the last six months notably improved by 60.53%, alongside a downfall of -20.43% for the period of the last 12 months. The shares increased approximately by 3.39% in the 7-day charts and went down by 54.43% in the period of the last 30 days. Common stock shares were driven by 128.55% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts